Global multi-stakeholder endorsement of the MAFLD definition

Nahum Méndez-Sánchez; Elisabetta Bugianesi; Robert G. Gish; Frank Lammert; Herbert Tilg; Mindie H. Nguyen; Shiv K. Sarin; Núria Fabrellas; Shira Zelber-Sagi; Jian Gao Fan; Gamal Shiha; Giovanni Targher; Ming-Hua Zheng; Wah-Kheong Chan; Shlomo Vinker; Takumi Kawaguchi; Laurent Castera; Yusuf Yilmaz; Marko Korenjak; C. Wendy Spearman; Mehmet Ungan; Melissa Palmer; Mortada El-Shabrawi; Hans Juergen Gruss; Jean François Dufour; Anil Dhawan; Heiner Wedemeyer; Jacob George; Luca Valenti; Yasser Fouad; Manuel Romero-Gomez; Mohammed Eslam; Global multi-stakeholder consensus on the redefinition of fatty liver disease; Paul N. Brennan; Gang Chen; Lei Li

doi:10.1016/S2468-1253(22)00062-0

Global multi-stakeholder endorsement of the MAFLD definition

Nahum Méndez-Sánchez, Elisabetta Bugianesi, Robert G. Gish, Frank Lammert, Herbert Tilg, Mindie H. Nguyen, Shiv K. Sarin, Núria Fabrellas, Shira Zelber-Sagi, Jian Gao Fan, Gamal Shiha, Giovanni Targher, Ming-Hua Zheng, Wah-Kheong Chan, Shlomo Vinker, Takumi Kawaguchi, Laurent Castera, Yusuf Yilmaz, Marko Korenjak, C. Wendy SpearmanMehmet Ungan, Melissa Palmer, Mortada El-Shabrawi, Hans Juergen Gruss, Jean François Dufour, Anil Dhawan, Heiner Wedemeyer, Jacob George, Luca Valenti, Yasser Fouad, Manuel Romero-Gomez, Mohammed Eslam, Global multi-stakeholder consensus on the redefinition of fatty liver disease, Paul N. Brennan, Gang Chen, Lei Li

College of Medicine and Public Health

Research output: Contribution to journal › Letter › peer-review

180 Citations (Scopus)

Abstract

Comprising over 1000 signatories representative of multiple stakeholders, including hepatologists, internists, diabetologists, endocrinologists, paediatricians, primary-care providers, nephrologists, cardiologists, pathologists, patient advocates, nurses, nutritionists, and pharmaceutical experts from over 134 countries, we—the undersigned—endorse both the name metabolic (dysfunction)-associated fatty liver disease (MAFLD) as an overarching term and its definition for fatty liver diseases associated with metabolic dysregulation. 1 , 2 , 3 We advocate for this change because it more accurately reflects the underlying pathogenesis of the disease than does the previously used term, non-alcoholic fatty liver disease (NAFLD). Furthermore, we believe that this designation will enhance our ability to advance the science of fatty liver disease and to improve patient care. 4 , 5 This open letter represents the voices of individuals and multiple stakeholders across the global liver health community; it is not intended to devalue any other initiative, but to complement and inform them.

Original language	English
Pages (from-to)	388-390
Number of pages	3
Journal	The Lancet Gastroenterology and Hepatology
Volume	7
Issue number	5
DOIs	https://doi.org/10.1016/S2468-1253(22)00062-0
Publication status	Published - May 2022

Keywords

metabolic (dysfunction) associated fatty liver disease (MAFLD)
Fatty liver disease
metabolic dysregulation
stakeholders

Access to Document

10.1016/S2468-1253(22)00062-0Licence: In Copyright

Cite this

Méndez-Sánchez, N., Bugianesi, E., Gish, R. G., Lammert, F., Tilg, H., Nguyen, M. H., Sarin, S. K., Fabrellas, N., Zelber-Sagi, S., Fan, J. G., Shiha, G., Targher, G., Zheng, M.-H., Chan, W.-K., Vinker, S., Kawaguchi, T., Castera, L., Yilmaz, Y., Korenjak, M., ... Li, L. (2022). Global multi-stakeholder endorsement of the MAFLD definition. The Lancet Gastroenterology and Hepatology, 7(5), 388-390. https://doi.org/10.1016/S2468-1253(22)00062-0

@article{3b9bd4893b7d4482b5901e31560bbc80,

title = "Global multi-stakeholder endorsement of the MAFLD definition",

abstract = "Comprising over 1000 signatories representative of multiple stakeholders, including hepatologists, internists, diabetologists, endocrinologists, paediatricians, primary-care providers, nephrologists, cardiologists, pathologists, patient advocates, nurses, nutritionists, and pharmaceutical experts from over 134 countries, we—the undersigned—endorse both the name metabolic (dysfunction)-associated fatty liver disease (MAFLD) as an overarching term and its definition for fatty liver diseases associated with metabolic dysregulation. 1 , 2 , 3 We advocate for this change because it more accurately reflects the underlying pathogenesis of the disease than does the previously used term, non-alcoholic fatty liver disease (NAFLD). Furthermore, we believe that this designation will enhance our ability to advance the science of fatty liver disease and to improve patient care. 4 , 5 This open letter represents the voices of individuals and multiple stakeholders across the global liver health community; it is not intended to devalue any other initiative, but to complement and inform them.",

keywords = "metabolic (dysfunction) associated fatty liver disease (MAFLD), Fatty liver disease, metabolic dysregulation, stakeholders",

author = "Nahum M{\'e}ndez-S{\'a}nchez and Elisabetta Bugianesi and Gish, {Robert G.} and Frank Lammert and Herbert Tilg and Nguyen, {Mindie H.} and Sarin, {Shiv K.} and N{\'u}ria Fabrellas and Shira Zelber-Sagi and Fan, {Jian Gao} and Gamal Shiha and Giovanni Targher and Ming-Hua Zheng and Wah-Kheong Chan and Shlomo Vinker and Takumi Kawaguchi and Laurent Castera and Yusuf Yilmaz and Marko Korenjak and Spearman, {C. Wendy} and Mehmet Ungan and Melissa Palmer and Mortada El-Shabrawi and Gruss, {Hans Juergen} and Dufour, {Jean Fran{\c c}ois} and Anil Dhawan and Heiner Wedemeyer and Jacob George and Luca Valenti and Yasser Fouad and Manuel Romero-Gomez and Mohammed Eslam and {Global multi-stakeholder consensus on the redefinition of fatty liver disease} and Abate, {Maria Lorena} and Bahaa Abbas and Abbassy, {Ahmed Amr} and {Abd El Ghany}, Waleed and {Abd Elkhalek}, Amira and {Abd ElMajeed}, Emad and Mohammad Abdalgaber and Marwa Abdallah and Nourhan Abdallah and Shereen Abdelaleem and Yasser Abdelghani and Wael Abdelghany and Abdelhalim, {Safaa Mohamed} and Wafaa Abdelhamid and Nehal Abdelhamid and Abdelkader, {Nadia A.} and Elsayed Abdelkreem and Abdelmohsen, {Aly Mohamed} and Abdelrahman, {Awny Ali} and Abd-elsalam, {Sherief M.} and Doaa Abdeltawab and Abdulbaset Abduh and Nada Abdulhakam and Maheeba Abdulla and Navid Abedpoor and Ludovico Abenavoli and Fredrik {\AA}berg and Omala Ablack and {Abo elftouh}, Mostafa and Abo-Amer, {Yousry Esam Eldin} and Ashraf Aboubkr and Alaa Aboud and Abouelnaga, {Amr M.} and Aboufarrag, {Galal A.} and Ashraf Aboutaleb and Leticia Abundis and Gupse Adalı and Enrique Adames and Leon Adams and Danjuma Adda and Noor Adel and Nada Adel and {Adel Sayed}, Muhammad and Afaa, {Taiba Jibril} and Nawal Afredj and Gulnara Aghayeva and Alessio Aghemo and Aguilar-Salinas, {Carlos A.} and Walid Ahmady and Golo Ahlenstiel and Wafaa Ahmed and Amira Ahmed and Ahmed, {Samah Nasser} and {Mostafa Ahmed}, Heba and Rasha Ahmed and Elmar Aigner and Mesut Akarsu and Maisam Akroush and Umit Akyuz and {Al Mahtab}, Mamun and {Al Qadiri}, Tahani and {Al Rawahi}, Yusriya and {AL rubaee}, Razzaq and {Al Saffar}, Muna and Shahinul Alam and Zaid Al-Ani and Agust{\'i}n Albillos and Mohamed Alboraie and Said Al-Busafi and Mohamed Al-Emam and Jawaher Alharthi and Kareem Ali and Ali, {Basma Abdelmoez} and Mohammad Ali and Ali, {Raja Affendi Raja} and Anna Alisi and AL-Khafaji, {Ali Raad} and Maryam Alkhatry and {Abdelmoez Ali}, Basma and Rocio Aller and Yahya Almansoury and Khalid Al-Naamani and Alaa Alnakeeb and Anna Alonso and Alqahtani, {Saleh A.} and Leina Alrabadi and Khalid Alswat and Mahir Altaher and Turki Altamimi and Jose Altamirano and Alvares-da-Silva, {Mario R.} and {Adel M. Aly}, Elsragy and Amgad Alzahaby and Ahmed Alzamzamy and Keisuke Amano and Amer, {Maysa A.} and Amin, {Mona A.} and Amin, {Sayed A.} and Amir, {Ashraf A.} and Javier Ampuero and Noha Anas and Pietro Andreone and Andriamandimby, {Soa Fy} and Mahmoud Anees and Peltec Angela and Manal Antonios and Wael Arafat and {Moreno Araya}, Jose and Juan Armendariz-Borunda and Armstrong, {Matthew J.} and Hassan Ashktorab and Patricia Aspichueta and Fathia Assal and Mira Atef and Dina Attia and Hoda Atwa and Reham Awad and Awad, {Mohyeldeen Abd Elaziz} and Sally Awny and Obafemi Awolowo and Awuku, {Yaw Asante} and Ibrahim Ayada and Aye, {Than Than} and Sherif Ayman and Hedy Ayman and Hesham Ayoub and Azmy, {Hosny M.} and Babaran, {Romiro P.} and Omneya Badreldin and Ahmed Badry and Bah{\c c}ecioğlu, {İbrahim Halil} and Amira Bahour and Jiajia Bai and Yasemin Balaban and Muthuswamy Balasubramanyam and Khaled Bamakhrama and Banales, {Jesus M.} and Babu Bangaru and Jianfeng Bao and Barahona, {Jorge Suazo} and Salma Barakat and Barbalho, {Sandra Maria} and Bikwa Barbra and Beatriz Barranco and Francisco Barrera and Ulrich Baumann and Shamardan Bazeed and Eva Bech and Aourarh Benayad and Andreas Benesic and David Bernstein and Fernando Bessone and Susie Birney and Cyrille Bisseye and Martin Blake and Bilal Bobat and Leonilde Bonfrate and Bordin, {Dmitry S.} and Francisco Bosques-Padilla and Jerome Boursier and Boushab, {Boushab Mohamed} and David Bowen and {Medina Bravo}, Patricia and Brennan, {Paul N.} and Bisi Bright and Ilse Broekaert and Xabier Buque and Diego Burgos-Santamar{\'i}a and Julio Burman and Luca Busetto and Byrne, {Chris D.} and Cabral-Prodigalidad, {Patricia Anne I.} and Guillermo Cabrera-Alvarez and Wei Cai and Francesca Cainelli and Caliskan, {Ali Riza} and Ali Canbay and Ana Cano-Contreras and Cao, {Hai Xia} and Zhujun Cao and Andres Carrion and Francesca Carubbi and Teresa Casanovas and {Iv{\'o}n Castellanos Fern{\'a}ndez}, Marlen and Jin Chai and Chan, {Siew Pheng} and Phunchai Charatcharoenwitthaya and Norberto Chavez-Tapia and Kazuaki Chayama and Jinjun Chen and Lin Chen and Zhong-Wei Chen and Huiting Chen and Sui-Dan Chen and Qiang Chen and Yaxi Chen and Gang Chen and Chen, {En Quang} and Fei Chen and Chen, {Pei Jer} and Robert Cheng and Wendy Cheng and Chieh, {Jack Tan Wei} and Imad Chokr and Evangelos Cholongitas and Ashok Choudhury and Abhijit Chowdhury and Chukwudike, {Evaristus Sunday} and Stefano Ciardullo and Michelle Clayton and Karine Clement and Cloa, {Marie Michelle} and Lei Li and Tim Mitchell and Kate Muller and Yan Wang and Alan Wigg",

year = "2022",

month = may,

doi = "10.1016/S2468-1253(22)00062-0",

language = "English",

volume = "7",

pages = "388--390",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Ltd.",

number = "5",

}

Méndez-Sánchez, N, Bugianesi, E, Gish, RG, Lammert, F, Tilg, H, Nguyen, MH, Sarin, SK, Fabrellas, N, Zelber-Sagi, S, Fan, JG, Shiha, G, Targher, G, Zheng, M-H, Chan, W-K, Vinker, S, Kawaguchi, T, Castera, L, Yilmaz, Y, Korenjak, M, Spearman, CW, Ungan, M, Palmer, M, El-Shabrawi, M, Gruss, HJ, Dufour, JF, Dhawan, A, Wedemeyer, H, George, J, Valenti, L, Fouad, Y, Romero-Gomez, M, Eslam, M, Global multi-stakeholder consensus on the redefinition of fatty liver disease, Brennan, PN, Chen, G & Li, L 2022, 'Global multi-stakeholder endorsement of the MAFLD definition', The Lancet Gastroenterology and Hepatology, vol. 7, no. 5, pp. 388-390. https://doi.org/10.1016/S2468-1253(22)00062-0

TY - JOUR

T1 - Global multi-stakeholder endorsement of the MAFLD definition

AU - Méndez-Sánchez, Nahum

AU - Bugianesi, Elisabetta

AU - Gish, Robert G.

AU - Lammert, Frank

AU - Tilg, Herbert

AU - Nguyen, Mindie H.

AU - Sarin, Shiv K.

AU - Fabrellas, Núria

AU - Zelber-Sagi, Shira

AU - Fan, Jian Gao

AU - Shiha, Gamal

AU - Targher, Giovanni

AU - Zheng, Ming-Hua

AU - Chan, Wah-Kheong

AU - Vinker, Shlomo

AU - Kawaguchi, Takumi

AU - Castera, Laurent

AU - Yilmaz, Yusuf

AU - Korenjak, Marko

AU - Spearman, C. Wendy

AU - Ungan, Mehmet

AU - Palmer, Melissa

AU - El-Shabrawi, Mortada

AU - Gruss, Hans Juergen

AU - Dufour, Jean François

AU - Dhawan, Anil

AU - Wedemeyer, Heiner

AU - George, Jacob

AU - Valenti, Luca

AU - Fouad, Yasser

AU - Romero-Gomez, Manuel

AU - Eslam, Mohammed

AU - Global multi-stakeholder consensus on the redefinition of fatty liver disease

AU - Abate, Maria Lorena

AU - Abbas, Bahaa

AU - Abbassy, Ahmed Amr

AU - Abd El Ghany, Waleed

AU - Abd Elkhalek, Amira

AU - Abd ElMajeed, Emad

AU - Abdalgaber, Mohammad

AU - Abdallah, Marwa

AU - Abdallah, Nourhan

AU - Abdelaleem, Shereen

AU - Abdelghani, Yasser

AU - Abdelghany, Wael

AU - Abdelhalim, Safaa Mohamed

AU - Abdelhamid, Wafaa

AU - Abdelhamid, Nehal

AU - Abdelkader, Nadia A.

AU - Abdelkreem, Elsayed

AU - Abdelmohsen, Aly Mohamed

AU - Abdelrahman, Awny Ali

AU - Abd-elsalam, Sherief M.

AU - Abdeltawab, Doaa

AU - Abduh, Abdulbaset

AU - Abdulhakam, Nada

AU - Abdulla, Maheeba

AU - Abedpoor, Navid

AU - Abenavoli, Ludovico

AU - Åberg, Fredrik

AU - Ablack, Omala

AU - Abo elftouh, Mostafa

AU - Abo-Amer, Yousry Esam Eldin

AU - Aboubkr, Ashraf

AU - Aboud, Alaa

AU - Abouelnaga, Amr M.

AU - Aboufarrag, Galal A.

AU - Aboutaleb, Ashraf

AU - Abundis, Leticia

AU - Adalı, Gupse

AU - Adames, Enrique

AU - Adams, Leon

AU - Adda, Danjuma

AU - Adel, Noor

AU - Adel, Nada

AU - Adel Sayed, Muhammad

AU - Afaa, Taiba Jibril

AU - Afredj, Nawal

AU - Aghayeva, Gulnara

AU - Aghemo, Alessio

AU - Aguilar-Salinas, Carlos A.

AU - Ahmady, Walid

AU - Ahlenstiel, Golo

AU - Ahmed, Wafaa

AU - Ahmed, Amira

AU - Ahmed, Samah Nasser

AU - Mostafa Ahmed, Heba

AU - Ahmed, Rasha

AU - Aigner, Elmar

AU - Akarsu, Mesut

AU - Akroush, Maisam

AU - Akyuz, Umit

AU - Al Mahtab, Mamun

AU - Al Qadiri, Tahani

AU - Al Rawahi, Yusriya

AU - AL rubaee, Razzaq

AU - Al Saffar, Muna

AU - Alam, Shahinul

AU - Al-Ani, Zaid

AU - Albillos, Agustín

AU - Alboraie, Mohamed

AU - Al-Busafi, Said

AU - Al-Emam, Mohamed

AU - Alharthi, Jawaher

AU - Ali, Kareem

AU - Ali, Basma Abdelmoez

AU - Ali, Mohammad

AU - Ali, Raja Affendi Raja

AU - Alisi, Anna

AU - AL-Khafaji, Ali Raad

AU - Alkhatry, Maryam

AU - Abdelmoez Ali, Basma

AU - Aller, Rocio

AU - Almansoury, Yahya

AU - Al-Naamani, Khalid

AU - Alnakeeb, Alaa

AU - Alonso, Anna

AU - Alqahtani, Saleh A.

AU - Alrabadi, Leina

AU - Alswat, Khalid

AU - Altaher, Mahir

AU - Altamimi, Turki

AU - Altamirano, Jose

AU - Alvares-da-Silva, Mario R.

AU - Adel M. Aly, Elsragy

AU - Alzahaby, Amgad

AU - Alzamzamy, Ahmed

AU - Amano, Keisuke

AU - Amer, Maysa A.

AU - Amin, Mona A.

AU - Amin, Sayed A.

AU - Amir, Ashraf A.

AU - Ampuero, Javier

AU - Anas, Noha

AU - Andreone, Pietro

AU - Andriamandimby, Soa Fy

AU - Anees, Mahmoud

AU - Angela, Peltec

AU - Antonios, Manal

AU - Arafat, Wael

AU - Moreno Araya, Jose

AU - Armendariz-Borunda, Juan

AU - Armstrong, Matthew J.

AU - Ashktorab, Hassan

AU - Aspichueta, Patricia

AU - Assal, Fathia

AU - Atef, Mira

AU - Attia, Dina

AU - Atwa, Hoda

AU - Awad, Reham

AU - Awad, Mohyeldeen Abd Elaziz

AU - Awny, Sally

AU - Awolowo, Obafemi

AU - Awuku, Yaw Asante

AU - Ayada, Ibrahim

AU - Aye, Than Than

AU - Ayman, Sherif

AU - Ayman, Hedy

AU - Ayoub, Hesham

AU - Azmy, Hosny M.

AU - Babaran, Romiro P.

AU - Badreldin, Omneya

AU - Badry, Ahmed

AU - Bahçecioğlu, İbrahim Halil

AU - Bahour, Amira

AU - Bai, Jiajia

AU - Balaban, Yasemin

AU - Balasubramanyam, Muthuswamy

AU - Bamakhrama, Khaled

AU - Banales, Jesus M.

AU - Bangaru, Babu

AU - Bao, Jianfeng

AU - Barahona, Jorge Suazo

AU - Barakat, Salma

AU - Barbalho, Sandra Maria

AU - Barbra, Bikwa

AU - Barranco, Beatriz

AU - Barrera, Francisco

AU - Baumann, Ulrich

AU - Bazeed, Shamardan

AU - Bech, Eva

AU - Benayad, Aourarh

AU - Benesic, Andreas

AU - Bernstein, David

AU - Bessone, Fernando

AU - Birney, Susie

AU - Bisseye, Cyrille

AU - Blake, Martin

AU - Bobat, Bilal

AU - Bonfrate, Leonilde

AU - Bordin, Dmitry S.

AU - Bosques-Padilla, Francisco

AU - Boursier, Jerome

AU - Boushab, Boushab Mohamed

AU - Bowen, David

AU - Medina Bravo, Patricia

AU - Brennan, Paul N.

AU - Bright, Bisi

AU - Broekaert, Ilse

AU - Buque, Xabier

AU - Burgos-Santamaría, Diego

AU - Burman, Julio

AU - Busetto, Luca

AU - Byrne, Chris D.

AU - Cabral-Prodigalidad, Patricia Anne I.

AU - Cabrera-Alvarez, Guillermo

AU - Cai, Wei

AU - Cainelli, Francesca

AU - Caliskan, Ali Riza

AU - Canbay, Ali

AU - Cano-Contreras, Ana

AU - Cao, Hai Xia

AU - Cao, Zhujun

AU - Carrion, Andres

AU - Carubbi, Francesca

AU - Casanovas, Teresa

AU - Ivón Castellanos Fernández, Marlen

AU - Chai, Jin

AU - Chan, Siew Pheng

AU - Charatcharoenwitthaya, Phunchai

AU - Chavez-Tapia, Norberto

AU - Chayama, Kazuaki

AU - Chen, Jinjun

AU - Chen, Lin

AU - Chen, Zhong-Wei

AU - Chen, Huiting

AU - Chen, Sui-Dan

AU - Chen, Qiang

AU - Chen, Yaxi

AU - Chen, Gang

AU - Chen, En Quang

AU - Chen, Fei

AU - Chen, Pei Jer

AU - Cheng, Robert

AU - Cheng, Wendy

AU - Chieh, Jack Tan Wei

AU - Chokr, Imad

AU - Cholongitas, Evangelos

AU - Choudhury, Ashok

AU - Chowdhury, Abhijit

AU - Chukwudike, Evaristus Sunday

AU - Ciardullo, Stefano

AU - Clayton, Michelle

AU - Clement, Karine

AU - Cloa, Marie Michelle

AU - Li, Lei

AU - Mitchell, Tim

AU - Muller, Kate

AU - Wang, Yan

AU - Wigg, Alan

PY - 2022/5

Y1 - 2022/5

N2 - Comprising over 1000 signatories representative of multiple stakeholders, including hepatologists, internists, diabetologists, endocrinologists, paediatricians, primary-care providers, nephrologists, cardiologists, pathologists, patient advocates, nurses, nutritionists, and pharmaceutical experts from over 134 countries, we—the undersigned—endorse both the name metabolic (dysfunction)-associated fatty liver disease (MAFLD) as an overarching term and its definition for fatty liver diseases associated with metabolic dysregulation. 1 , 2 , 3 We advocate for this change because it more accurately reflects the underlying pathogenesis of the disease than does the previously used term, non-alcoholic fatty liver disease (NAFLD). Furthermore, we believe that this designation will enhance our ability to advance the science of fatty liver disease and to improve patient care. 4 , 5 This open letter represents the voices of individuals and multiple stakeholders across the global liver health community; it is not intended to devalue any other initiative, but to complement and inform them.

AB - Comprising over 1000 signatories representative of multiple stakeholders, including hepatologists, internists, diabetologists, endocrinologists, paediatricians, primary-care providers, nephrologists, cardiologists, pathologists, patient advocates, nurses, nutritionists, and pharmaceutical experts from over 134 countries, we—the undersigned—endorse both the name metabolic (dysfunction)-associated fatty liver disease (MAFLD) as an overarching term and its definition for fatty liver diseases associated with metabolic dysregulation. 1 , 2 , 3 We advocate for this change because it more accurately reflects the underlying pathogenesis of the disease than does the previously used term, non-alcoholic fatty liver disease (NAFLD). Furthermore, we believe that this designation will enhance our ability to advance the science of fatty liver disease and to improve patient care. 4 , 5 This open letter represents the voices of individuals and multiple stakeholders across the global liver health community; it is not intended to devalue any other initiative, but to complement and inform them.

KW - metabolic (dysfunction) associated fatty liver disease (MAFLD)

KW - Fatty liver disease

KW - metabolic dysregulation

KW - stakeholders

UR - http://www.scopus.com/inward/record.url?scp=85127533180&partnerID=8YFLogxK

U2 - 10.1016/S2468-1253(22)00062-0

DO - 10.1016/S2468-1253(22)00062-0

M3 - Letter

C2 - 35248211

AN - SCOPUS:85127533180

SN - 2468-1253

VL - 7

SP - 388

EP - 390

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

IS - 5

ER -

Global multi-stakeholder endorsement of the MAFLD definition

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this